Kewaunee Scientific Corporation (KEQU): Price and Financial Metrics


Kewaunee Scientific Corporation (KEQU)

Today's Latest Price: $12.02 USD

0.02 (0.17%)

Updated Feb 21 12:00am

Add KEQU to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 65 in Home Improvement & Goods

See all "A" rated Strong Buy stocks

KEQU Stock Summary

  • KEQU has a market capitalization of $34,734,306 -- more than approximately merely 11.35% of US stocks.
  • KEQU's price/sales ratio is 0.24; that's higher than the P/S ratio of merely 7.86% of US stocks.
  • With a year-over-year growth in debt of 152.33%, Kewaunee Scientific Corp's debt growth rate surpasses 90.27% of about US stocks.
  • Stocks that are quantitatively similar to KEQU, based on their financial statements, market capitalization, and price volatility, are UTI, CHS, EXPR, SUMR, and TLRD.
  • Visit KEQU's SEC page to see the company's official filings. To visit the company's web site, go to www.kewaunee.com.
KEQU Daily Price Range
KEQU 52-Week Price Range

KEQU Stock Price Chart More Charts


KEQU Price/Volume Stats

Current price $12.02 52-week high $31.65
Prev. close $12.00 52-week low $11.85
Day low $11.90 Volume 6,900
Day high $12.05 Avg. volume 9,063
50-day MA $13.13 Dividend yield 4.74%
200-day MA $16.55 Market Cap 33.06M

Kewaunee Scientific Corporation (KEQU) Company Bio


Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company was founded in 1906 and is based in Statesville, North Carolina.

KEQU Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$12.02$0.35 -97%

Below please find a table outlining a discounted cash flow forecast for KEQU, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Kewaunee Scientific Corp ranked in the 6st percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 97%. The most interesting components of our discounted cash flow analysis for Kewaunee Scientific Corp ended up being:

  • Interest coverage, a measure of earnings relative to interest payments, is -1.39 -- which is good for besting merely 10.79% of its peer stocks (US stocks in the Consumer Cyclical sector with positive cash flow).
  • The company's compound free cash flow growth rate over the past 5.42 years comes in at -0.27%; that's greater than merely 6.3% of US stocks we're applying DCF forecasting to.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-97%
1%-97%
2%-97%
3%-97%
4%-97%
5%-97%

EVC, FOSL, MOD, RLH, and YVR can be thought of as valuation peers to KEQU, in the sense that they are in the Consumer Cyclical sector and have a similar price forecast based on DCF valuation.


KEQU Latest News Stream


Event/Time News Detail
Loading, please wait...

KEQU Latest Social Stream


Loading social stream, please wait...

View Full KEQU Social Stream

KEQU Price Returns

1-mo -3.81%
3-mo -23.68%
6-mo N/A
1-year -60.61%
3-year -49.00%
5-year -24.58%
YTD -10.63%
2019 -58.34%
2018 17.53%
2017 21.56%
2016 41.22%
2015 2.94%

KEQU Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full KEQU Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6642 seconds.